Company Overview of Acton Pharmaceuticals, Inc.
Acton Pharmaceuticals, Inc. operates as a respiratory specialty pharmaceutical company, which acquires, develops, and commercializes products to treat allergic, pulmonary, and other respiratory related diseases. Its AEROSPAN Inhalation Aerosol is an orally inhaled corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 6 years of age and older. The company was founded in 2008 and is based in Marlborough, Massachusetts. As of October 21, 2013, Acton Pharmaceuticals, Inc. operates as a subsidiary of Meda AB.
225 Cedar Hill Street
Marlborough, MA 01752
Founded in 2008
Key Executives for Acton Pharmaceuticals, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Acton Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.